Membrane humidifier
US-9190677-B2 · Nov 17, 2015 · US
US10006842B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10006842-B2 |
| Application number | US-201314424574-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 19, 2013 |
| Priority date | Aug 30, 2012 |
| Publication date | Jun 26, 2018 |
| Grant date | Jun 26, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a simple method for producing a cell concentrate (other than human blood) in a short time with neither loss of cells nor an excessive burden on cells. Included is a method for producing a cell concentrate using an inside-out filtration system for processing a cell suspension, the system including: a cell suspension inlet port; a filtrate outlet port; a cell suspension outlet port; and hollow fiber separation membranes provided between the cell suspension inlet port and the cell suspension outlet port, wherein the membranes have a total cross-sectional area of 0.5-1.5 cm 2 , the membranes have an inside membrane area of 0.2 m 2 or less, the suspension is flowed inside the membranes at a linear velocity of 500-1200 cm/min, and the quotient of the division of the initial filtrate flow rate from the filtrate outlet port by the flow rate into the cell suspension inlet port is 0.4-0.7.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a cell concentrate comprising filtration of a cell suspension using an inside-out filtration system, the system comprising: a cell suspension inlet port; a filtrate outlet port; a cell suspension outlet port; and a set of hollow fiber separation membranes provided between the cell suspension inlet port and the cell suspension outlet port, wherein the hollow fiber separation membranes have a total cross-sectional area of 0.5 cm 2 to 1.5 cm 2 , the hollow fiber separation membranes have an inside membrane area of 0.2 m 2 or less, the cell suspension is flowed inside the hollow fiber separation membranes at a linear velocity of 500 cm/min to 1200 cm/min, the quotient of the division of an initial filtrate flow rate from the filtrate outlet port by a flow rate into the cell suspension inlet port is 0.4 to 0.7, a cell recovery rate is at least 81%, and a filtration time, measured from the start to the end of filtration of 1000 ml of the cell suspension, is 330 seconds or less. 2. The method for producing a cell concentrate according to claim 1 , wherein the hollow fiber separation membranes have an inner diameter of 300 μm to 1000 μm. 3. The method for producing a cell concentrate according to claim 1 , wherein the hollow fiber separation membranes have an average pore size of 0.1 μm or more. 4. The method for producing a cell concentrate according to claim 1 , wherein the hollow fiber separation membranes are made of a polysulfone-, polyolefin-, or cellulose-based material. 5. The method for producing a cell concentrate according to claim 1 , wherein the hollow fiber separation membranes are made of polyethersulfone. 6. The method for producing a cell concentrate according to claim 1 , wherein the cell suspension is an immune cell suspension. 7. A method for producing a cell concentrate, comprising the steps of: washing a cell concentrate obtained by the production method according to claim 1 by repeating dilution with a liquid free from cells and concentration; and further concentrating the resulting concentrate. 8. A method for cryopreserving cells, comprising cryopreserving a cell concentrate obtained by the production method according to claim 1 with liquid nitrogen. 9. The method of claim 1 , wherein the cell suspension is a human cell suspension. 10. The method of claim 9 , wherein the human cell suspension is human immune cell suspension.
Hollow fibers or tubes (hollow fiber modules in general B01D63/02) · CPC title
characterised by the fibre diameter · CPC title
Hollow fibre modules · CPC title
filtration · CPC title
Apparatus therefor · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.